Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation

Neuropsychopharmacology

Volumn 27, Issue 4, 2002, Pages 672-683

  Bartzokis, George ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d NONE   (United States)

Author keywords

Association regions; Brain; Connectivity; Development; Frontal; Myelin; Neural networks; Schizophrenia; Temporal; White matter

Indexed keywords

APOLIPOPROTEIN D; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; NEUROSTEROID;

ADOLESCENCE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN MATURATION; BRAIN SIZE; BRAIN TOXICITY; COGNITIVE DEFECT; DRUG EFFECT; ENVIRONMENTAL FACTOR; GRAY MATTER; HEREDITY; HUMAN; LIPID METABOLISM; METACHROMATIC LEUKODYSTROPHY; MYELINATION; NERVE CELL NETWORK; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STRESS; SYMPTOM; SYNAPTOGENESIS; WHITE MATTER;

EID: 0036791990     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00364-0     Document Type: Article

References (145)

1. Aboitiz F., Scheibel A.B., Fisher R.S., Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 598:1992;143-153.
2. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney W.E., Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 53:1996;425-436.
3. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of olygodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 31:2000;219-231.
4. Andreasen N.C., Napoulos P., O' Leary D.S., Miller D.D., Wassink T., Flaum M. Defining the phenotype of schizophrenia. cognitive dysmetria and its neural mechanisms Biol Psychiatry. 46:1999;908-920.
5. Assies J., Lieverse R., Vreken P., Wanders R.J.A., Dingemans P.M.J.A., Linszen D.H. Significantly reduced docosahexaenoic and docosapentaenoic acid concentration in erithrocyte membranes from schizophrenic patients compared to matched control group. Biol Psychiatry. 49:2001;510-522.
6. Baare W.F.C., van Oel C.J., Hulshoff Pol H.E., Schnack H.G., Durston S., Sitskoorn M.M., Kahn R.S. Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry. 58:2001;33-40.
7. Barbaccia M.L., Affricano D., Purdy R.H., Maciocco E., Spiga F., Biggio G. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharm. 25:2001;489-497.
8. Bartha R., Al-Semaan Y.M., Williamson P.C., Drost D.J., Malla A.K., Carr T.J., Densmore M., Canaran G., Neufeld R.W.J. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry. 45:1999;1403-1411.
9. Bartzokis G., Beckson M., Lu P.H., Edwards N., Bridge P., Mintz J. Brain maturation is arrested in chronic cocaine addicts. Biol Psychiatry. 51:2002;605-611. a.
10. Bartzokis G., Beckson M., Lu P.H., Nuechterlein K., Edwards N., Mintz J. Age-related changes in frontal and temporal lobe volumes in men. a magnetic resonance imaging study Arch Gen Psychiatry. 58:2001;461-465.
11. Bartzokis G., Mintz J., Marx P., Osborn D., Gutkind D., Chiang F., Phelan C.K., Marder S. Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Res Imaging. 11:1993;993-1006.
12. Bartzokis G, Nuechterlein KH, Lu PH, Edwards N, Mintz J (2002b): Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study. (submitted)
13. Bassett A.S., Chow E.W. 22q11 deletion syndrome. a genetic subtype of schizophrenia Biol Pschiatry. 46:1999;882-891.
14. Basson B.R., Kinion B.J., Taylor C.C., Szymanski K.A., Gilmore J.A., Tollefson G.D. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry. 62:2001;231-238.
15. Baulieu E.E., Schumacher M. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids. 65:2000;605-612.
16. Bearden C.E., van Erp T., Glahn D., Wang P.P., Monterosso J.R., Zackai E., Emanuel B., Cannon T.D. Structural and functional neuroanatomy in the 22q deletion syndrome. Biol Psychiatry. 49:2001;19S.
17. Benes F.M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry. 51:1994;477-484.
18. Bhakoo K.K., Pearce D. In vitro expression of N-acetyl aspartate in oligodendrocytes. Implications for proton magnetic resonance spectroscopy signal in vivo J Neurochem. 74:2000;254-262.
19. Bock J., Braun K. Blockade of N-methyl-D-aspartate receptor activation suppresses learning-induced synaptic elimination. Proc Natl Acad Sci USA. 96:1999;2485-2490.
20. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures Arch Gen Psychiatry. 49:1992;921-926.
21. Buchanan R.W., Vladar K., Barta P.E., Pearlson G.D. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry. 155:1998;1049-1055.
22. Buchsbaum M.S., Tang C.Y., Peled S., Gudbjartsson H., Lu D., Hazlett E.A., Downhill J., Haznedar M., Fallon J.H., Atlas S.W. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 9:1998;425-430.
23. Cannon T.D., van Erp T.G., Huttunen M., Lonnqvist J., Salonen O., Valanne L., Poutanen V.P., Standertskjold-Nordenstam C.G., Gur R.E., Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 55:1998;1084-1091.
24. Castle D., Sham P., Murray R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Res. 33:1998;179-183.
25. Chan J.R., Phillips L.J., Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci USA. 95:1998;10459-10464.
26. Chance S.A., Highley J.R., Esiri M.M., Crow T.J. Fiber content of the fornix in schizophrenia. lack of evidence for a primary limbic encephalopathy Am J Psychiatry. 156:1999;1720-1724.
27. Chow E.W., Mikulis D.J., Zipursky R.B., Scutt L.E., Weksberg R., Bassett A.S. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry. 46:1999;1436-1442.
28. Cotter D., Mackay D., Chana G., Beasley C., Landau S., Everall I.P. Reduced neuronal size and glia cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex. 12:2002;386-394.
29. Davis K.L., Buchsbaum M.S., Shihabuddin L., Spiegel-Cohen J., Metzger M., Frecska E., Keefe R.S., Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 43:1998;783-793.
30. Degreef G., Ashtari M., Bogerts B., Bilder R.M., Jody D.N., Alvir J.M., Lieberman J.A. Volumes of ventricular system subdivisions measured from magnetic resonance images in first episode schizophrenic patients. Arch Gen Psychiatry. 49:1992;531-537.
31. Demerens C., Stankoff B., Zalc B., Lubetzki C., Eliprodil Stimulates CNS myelination. new prospects for multiple sclerosis? Neurology. 1999:1999;346-350.
32. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic brain process. A study of progressive brain structural change subsequent to the onset of schizophrenia Psychiatry Res: Neuroimaging. 74:1997;129-140.
33. DeLisi L.E., Striktzke P., Riordan H., Holan V., Boccio A., Kushner M., McClelland J., Van Eyl O., Anand A. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry. 31:1992;241-254.
34. DeLisi L.E. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophrenia Res. 23:1997;119-129.
35. Demczuk S., Aurias A. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. a review Ann Genet. 38:1995;59-76.
36. Desarnaud F., Do Thi A.N., Brown A.M., Lemke G., Suter U., Baulieu E.E., Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem. 71:1998;1765-1768.
37. Du Montcel S.T., Mendizabal H., Ayme S., Levy A., Philip N. Prevalence of 22q11 microdeletion. J Med Genet. 33:1996;719.
38. Eliez S., Antonarakis S.E., Morris M.A., Dahoun S.P., Reiss A.L. Parental origin of the deletion 22q11.2 and brain development in velofacial syndrome. Arch Gen Psychiatry. 58:2001;64-68.
39. Eliez S., Schmitt J.E., White C.D., Reiss A.L. Children and adolescents with velocardiofacial syndrome. a volumetric MRI study Am J Psychiatry. 157:2000;409-415.
40. Etienne P., Baudry M. Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology; an integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes. J Neural Transm. 29(suppl):1990;39-48.
41. Foong J., Maier M., Barker G.J., Brocklehurst S., Miller D.H., Ron M.A. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurolog Neurosurg Psychiatry. 68:2000;70-74.
42. Friedman J.I., Harvey P.D., Kamether E., Byne W., Davis K.L. Cognitive and functional changes with aging in schizophrenia. Biol Psychiatry. 46:1999;921-928.
43. Friston K.J. The disconnection hypothesis. Schizophr Res. 30:1998;115-125.
44. Friston K.J., Frith C.D. Schizophrenia. a disconnection syndrome? Clin Neurosci. 3:1995;89-95.
45. Fukuzako H., Fukuzako T., Hashiguchi T., Kodama S., Takigawa M., Fujimoto T. Changes in levels of phosphorus metabolites in temporal lobes of drug-naïve schizophrenic patients. Am J Psychiatry. 156:1999;1205-1208.
46. Fuster J.M. Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatrica Scandinavia. 99:1999;51-57.
47. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., Paus T., Evans A.C., Rapoport J.L. Brain development during childhood and adolescence. a longitudinal MRI study Nat Neurosci. 2:1999;861-863. a.
48. Giedd J.N., Jeffries N.O., Blumenthal J., Castellanos F.X., Vaituzis A.C., Fernandez T., Hamburgen S.D., Liu H., Nelson J., Bedwell J., Tran L., Leane M., Nicolson R., Rapoport J.L. Childhood-onset schizophrenia. progressive brain changes during adolescence Biol Psychiatry. 46:1999;892-898. b.
49. Gould E., Reeves A.J., Graziano M.S.A., Gross C.G. Neurogenesis in the neocortex of adult primates. Science. 286:1999;548-552.
50. Green M.F. Cortical oscillations and schizophrenia. Arch Gen Psychiatry. 56:1999;1007-1008.
51. Gur R.C., Turetsky B.I., Matsui M., Yan M., Bilker W., Hughett P., Gur R.E. Sex differences in brain gray and white matter in healthy young adults. correlations with cognitive performance J Neurosci. 19:1999;4065-4072.
52. Gur R.E., Cowell P.E., Latshaw A., Turetsky B.I., Grossman R.I., Arnold S.E., Bilker W.B., Gur R.C. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry. 57:2000;761-768. a.
53. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic-naïve and treated patients with schizophrenia. Am J Psychiatry. 155:1998;1711-1717.
54. Gur R.E., Turetsky B.I., Cowell P.E., Finkelman C., Maany V., Grossman R.I., Arnold S.E., Bilker W.B., Gur R.C. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry. 57:2000;769-775. b.
55. Haas G.L., Garratt L.S., Sweeney J.A. Delay to first antipsychotic medication in schizophrenia. impact on symptomology and clinical course of illness J Psychiatr Res. 32:1998;151-159.
56. Hafner H., Hambrecht M., Loffler W., Munk-Jorgensen P., Riecher-Rossler A. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med. 28:1998;351-365.
57. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA. 98:2001;4746-4751.
58. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain. 122:1999;593-624.
59. Harvey P.D., Moriarty P.J., Friedman J.I., White L., Parrella M., Mohs R.C., Davis K.L. Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia. less impairment in reading compared with other skill areas Biol Psychiatry. 47:2000;962-968.
60. Harvey P.D., Silverman J.M., Mohs R.C., Parrella M., White L., Powchik P., Davidson M., David K.L. Cognitive decline in late-life schizophrenia. a longitudinal study of geriatric chronically hospitalized patients Biol Psychiatry. 45:1999;32-40.
61. Haug H. Brain sizes, surfaces, and neuronal sizes of the cortex cerebri. a stereological investigation of man and his variability and a comparison with some mammals (primates, whales, marsupials, insectivores, and one elephant) Am J Anat. 180:1987;126-142.
62. Henderson D.C., Cagliero E., Gray C., Nasrallah R.A., Hayden D.L., Schoenfeld D.A., Goff D.C. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities. A five-year naturalistic study Am J Psychiatry. 157:2000;975-981.
63. Horrobin D.F., Bennett C.N. New gene targets related to schizophrenia and other psychiatric disorders. enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism Prostaglandins Leukotrines Essnt Fatty Acids. 60:1999;141-167.
64. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 387:1997;167-178.
65. Huttenlocher P.R. Synaptic density in the human frontal cortex. developmental changes and effects of aging Brain Res. 163:1979;195-205.
66. Hyde T.M., Ziegler J.C., Weinberger D.R. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 49:1992;401-406.
67. Illowsky B.P., Juliano D.M., Bigelow L.B., Weinberger D.R. Stability of CT scan findings in schizophrenia. results of an 8 year follow-up study J Neurology Neurosurgery Psychiatry. 51:1988;209-213.
68. Jernigan T.L., Archibald S.L., Berhow M.T., Sowell E.R., Foster D.S., Hesselink J.R. Cerebral structure on MRI, part I. localization of age-related changes Biol Psychiatry. 29:1991;55-67.
69. Kalman J., McConathy W., Araoz C., Kasa P., Lacko A.G. Apolipoprotein D in the aging brain and in Alzheimer's dementia. Neurol Res. 22:2000;330-336.
70. Kates W.R., Burnette C.P., Jabs E.W., Rutberg J., Murphy A.M., Gardos M.A., Geraghty M., Kaufmann W.E., Pearlson G.D. Regional cortical white matter reductions in velocardiofacial syndrome. A volumetric MRI analysis Biol Psychiatry. 49:2001;677-684.
71. Keshavan M.S., Rosenberg D., Sweeney J.A., Pettegrew J.W. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am J Psychiatry. 155:1998;774-778.
72. Khan M.M., Parikh V.V., Mahadik S.P. Effects of chronic exposure of antipsychotics on apolipoprotein D in rat brain. Biol Psychiatry. 51:2002;168S.
73. Kirkpatrick B., Conley R.C., Kakoyannis A., Reep R.L., Roberts R.C. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia. An unbiased cell-counting study Synapse. 34:1999;95-102.
74. Koenig H.L., Gong W.H., Pelissier P. Role of progesterone in peripheral nerve repair. Rev Reprod. 5:2000;189-199.
75. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry. 172:1998;110-120. [see comments].
76. Levy R., Goldman-Rakic P.S. Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp Brain Res. 133:2000;23-32.
77. Lieberman J., Chakos M., Wu H., Alvir J., Hoffman E., Robinson D., Bilder R. Longitudinal study of brain morpology in first episode schizophrenia. Biol Psychiatry. 49:2001;487-499.
78. Lieberman JA, Duncan G, Marx C, Grobin C, Morrow L (2001a): Atypical and Conventional Antipsychotic Drugs: Comparative Effects and Mechanism of Action. Abstracts of the 40th Annual Meeting of the ACNP, Hawaii, December 2001
79. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 55:1998;346-352.
80. Lim K.O., Hedehus M., Moseley M., de Crespigny A., Sullivan E.V., Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 56:1999;367-374.
81. Lim K.O., Zipursky R.B., Watts M.C., Pfefferbauum A. Decreased gray matter in normal aging. An in vivo magnetic resonance study J Gerontol. 47:1992;B26-B30.
82. Maier M., Ron M.A. Hippocampal age-related changes in schizophrenia. a proton magnetic resonance spectroscopy study Schizophrenia Res. 22:1996;5-17.
83. Marx C.E., Duncan G.E., Gilmore J.H., Lieberman J.A., Morrow A.L. Olanzapine increases allopregnenalone in the rat cerebral cortex. Biol Psychiatry. 47:2000;1000-1004.
84. Mathalon D.H., Sullivan E.V., Lim K.O., Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men. a longitudinal magnetic resonance imaging study Arch Gen Psychiatry. 58:2001;148-157.
85. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol Psychiatry. 45:1999;1099-1119.
86. McDonald J.W., Althomsons S.P., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med. 4:1998;291-297.
87. McGlashan T.H. Duration of untreated psychosis in first-episode schizophrenia. marker or determinant of course? Biol Psychiatry. 46:1999;899-907.
88. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry. 57:2000;637-648.
89. McGurk S.R., Moriarty P.J., Harvey P.D., Parrella M., White L., Davis K.L. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Res. 42:2000;47-55.
90. Melcangi R.C., Magnaghi I., Cavarretta L., Martini L., Piva F. Age-induced decrease of glycoprotein PO and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience. 85:1998;569-578.
91. Melkersson K.I., Hulting A.L., Brismar K.E. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry. 61:2000;742-749.
92. Mesulam M. Principles of Behavioral and Cognitive Neurology. 2nd ed:2000;Oxford Univ Press, New York.
93. Miller A.K., Alston R.L., Corsellis J.A. Variation with age in the volumes of grey and white matter in the cerebral hemisphere of man. measurements with an image analyser Neuropathol Appl Neurobiol. 6:1980;119-132.
94. Miller E.K. The prefrontal cortex and cognitive control. Nature Reviews Neuroscience. 1:2000;59-65.
95. Mimmack M.L., Ryan M., Baba H., Navarro-Ruiz J., Iritani S., Faull R.L.M., McKenna P.J., Jones P.B., Arai H., Starkey M., Emson P.C., Bahn S. Gene expression analysis in schizophrenia. Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 PANS. 99:2002;4680-4685.
96. Montpied P., de Bock F., Lerner-Natoli M., Bockaert J., Rondouin G. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res. 35:1999;135-146.
97. Murphy K.J., Regan C.M. Contributions of cell adhesion molecules to altered synaptic weighting during memory consolidation. Neurobiol Learn Mem. 70:1998;73-81.
98. Navarro A., Tolivia J., Astudillo A., del Valle E. Pattern of apolipoprotein D immunoreactivity in human brain. Neurosci Lett. 254:1998;17-20.
99. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. a meta-analytic study Arch Gen Psychiatry. 55:1998;433-440.
100. Nuechterlein K.H., Dawson M.E., Gitlin M., Vemtura J., Goldstein M.J., Snyder K.S., Yee C.M., Mintz J. A heuristic vulnerability/stress model of schizophrenic episodes. Schizoph Bull. 10:1986;300-312.
101. Ohara K., Xu H.D., Matsunaga T., Xu D.S., Huang X.Q., Gu G.F., Ohara K., Wang Z.C. Cerebral ventricle-brain ratio in monozygotic twins discordant and concordant for schizophrenia. Progress Neuro-Psychopharm Biol Psychiatry. 22:1998;1043-1050.
102. Ong W.Y., Lau C.P., Leong S.K., Kumar U., Suresh S., Patel S.C. Apolipoprotein D gene expression in the rat brain and light and electron microscopic immunocytochemistry of apolipoprotein D expression in the cerebellum of neonatal, immature adult rats. Neurosci. 1999; 90:1999;913-922.
103. Pakkenberg B., Gundersen H.J. Neocortical neuron number in humans. effect of sex and age J Comp Neurol. 384:1997;312-320.
104. Passe T.J., Rajagopalan P., Tupler L.A., Byrum C.E., MacFall J.R., Krishnan K.R.R. Age and sex effects on brain morphology. Prog Neuropsychopharmacol Biol Psychiatry. 21:1997;1231-1237.
105. Patel S.C., Asotra K., Patel Y.C., McConathy W.J., Patel R.C., Suresh S. Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport. 6:1995;653-6658.
106. Pearlson G.D., Marsh L. Structural brain imaging in schizophrenia. A selective review Biol Psychiatry. 46:1999;627-649.
107. Peters A., Morrison J.H., Rosene D.L., Hyman B.T. Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex. 8:1998;295-300.
108. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics. a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy Arch Gen Psychiatry. 48:1991;563-568.
109. Pfefferbaum A., Mathalon D.H., Sullivan E.V., Rawles J.M., Zipursky R.B., Lim K.O. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 51:1994;874-887.
110. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., Davis K.L. Alzheimer disease and related neurodegenerative disease in elderly patients with schizophrenia. Arch Gen Psychiatry. 55:1998;205-211.
111. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicholson R., Bedwell J., Leane M., Zijdenbos A., Paus T., Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study Arch Gen Psychiatry. 56:1999;649-654.
112. Rassart E., Bedirian A., Do Carmo S., Guinard O., Sirois J., Terrisse L., Milne R. Apolipoprotein D. Biochimi Biophys Acta. 1482:2000;185-198.
113. Raz N., Gunning F.M., Head D., Dupuis J.H., McQuain J., Briggs S.D., Loken W.J., Thorton A.E., Acker J.D. Selective aging of the human cerebral cortex observed in vivo. differential vulnerability of the prefrontal gray matter Cereb Cortex. 7:1997;268-282.
114. Sachdev P., Brodaty H., Rose N., Cathcart S. Schizophrenia with onset after age 50 years. 2. Neurological, neuropsychological and MRI investigation Br J Psychiatry. 175:1999;416-421.
115. Sanfilipo M., Lafargue T., Rusinek H., Arena L., Loneragan C., Lautin A., Feiner D., Rotrosen J., Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia. relationship to negative symptoms Arch Gen Psychiatry. 57:2000;471-480.
116. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 57:2000;925-935.
117. Schaeren-Wiemers N., Schaefer C., Valenzuela D.M., Yancopoulos G.D., Schwab M.E. Identification of new oligodendrocyte- and myelin-specific genes by a differential screening approach. J Neurochem. 65:1995;10-22.
118. Seidman L.J., Faraone S.V., Goldstein J.M., Goodman J.M., Kremen W.S., Toomey R., Tourville J., Kennedy D., Makris N., Caviness V.S., Tsuang M.T. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia. an MRI-based morphometric analysis Biol Psychiatry. 46:1999;941-954.
119. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis. A circuit based model of schizophrenia Biol Psychiatry. 45:1999;17-25.
120. Sestan N., Artevanis-Tsakonas S., Rakic P. Contact-dependent inhibition of cortical neurite growth mediated notch signaling. Science. 286:1999;741-746.
121. Sheline Y.I. Hippocampal atrophy in major depression. a result of depression-induced neurotoxicity Mol Psychiatry. 1:1996;298-299.
122. Srinivasan R. Spatial structure of the human alpha rhythm. global correlation in adults and local correlation in children Clin Neurophysiol. 110:1999;1351-1362.
123. Staal W.G., Hulshoff Pol H.E., Schnack H.G., Hoogendoorn M.L., Jellema K., Kahn R.S. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry. 157:2000;416-421.
124. Sullivan E.V., Marsh L., Mathalon D.H., Lim K.O., Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging. 16:1995;591-606.
125. Suresh S., Yan Z., Patel R.C., Patel Y.C., Patel S.C. Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. J Neurochem. 70:1998;242-251.
126. Symonds L.L., Archibald S.L., Grant I., Zisook S., Jernigan T.L. Does an increase in sulcal or ventricular fluid predict where brain tissue is lost? J Neuroimaging. 9:1999;201-209.
127. Takahashi S., Matsuura M., Tanabe E., Yara K., Nonaka K., Fukura Y., Kikuchi M., Kojima T. Age at onset of schizophrenia. gender differences and influence of temporal socioeconomic change Psychiatry Clin Neurosci. 54:2000;153-156.
128. Takao M., Koto A., Tanahashi N., Fukuuchi Y., Takagi M., Morinaga S. Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci. 167:1999;127-131.
129. Terry R.D., DeTeresa R., Hansen L.A. Neocortical cell counts in normal human adult aging. Ann Neurol. 21:1987;530-539.
130. Thomas E.A., Danielson P.E., Nelson P.A., Pribyl T.M., Hilbush B.S., Hasel K.W., Sutcliffe J.G. Clozapine increases apolipoprotein D expression in rodent brain. towards a mechanism for neuroleptic pharmacotherapy J Neurochem. 76:2001;789-796. a.
131. Thomas E.A., Dean B., Pavey G., Sutcliffe J.G. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects. Implications for the pathophysiology of psychiatric disorders PANS. 98:2001;4066-4071. b.
132. Thompson P.M., Giedd J.N., Woods R.P., MacDonald D., Evans A.C., Toga A.W. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature. 404:2000;190-193.
133. Tonkonogy J.M., Geller J.L. Late-onset paranoid psychosis as a distinct clinicopathologic entity. magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset Neuropsychiatry Neuropsychol Behav Neurol. 12:1999;230-235.
134. Uranova N., Orlovskaya D., Vikhreva O., Zimina L.et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 55:2001;597-610.
135. Valk J., van der Knaap M.S. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 1989;Springer-Verlag, New York.
136. Walder D.J., Walker E.F., Lewine R.J. Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biol Psychiatry. 48:2000;1121-1132.
137. Watzka M., Bidlingmaier F., Schramm J., Klingmuller D., Stoffel-Wagner B. Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J Neuroendocrinol. 11:1999;901-905.
138. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia. a search for common ground Schizophrenia Res. 16:1995;87-110.
139. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:1987;660-669.
140. Welham J., McLachlan G., Davies G., McGrath J. Heterogeneity in schizophrenia; mixture modeling of age-at-first-admission, gender and diagnosis. Acta Psychiatr Scand. 101:2000;312-317.
141. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry. 155:1998;1661-1670.
142. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 157:2000;16-25.
143. Wyatt R.J., Henter I.D. The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res. 32:1998;169-177.
144. Yakovlev P.I., Lecours A.R. The myelogenetic cycles of regional maturation of the brain. Minkowski A. Regional Development of the Brain in Early Life. 1967;3-70 Blackwell Scientific Publications, Boston.
145. Zwain I.H., Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology. 140:1999;3843-3852.